Supplemental Financial Information (Tables)

12 Months Ended

Dec. 31, 2013

Supplemental Financial Information

Schedule of interest expense (income), net

years ended December 31 (in millions)	2013			2012			2011
Interest expense	$	299		$	104		$	—
Interest and dividend income		(21	)		(20	)		(20	)
Interest expense (income), net	$	278		$	84		$	(20	)

Schedule of accounts payable and accrued liabilities

as of December 31 (in millions)	2013		2012
Sales rebates	$	1,401	$	1,616
Accounts payable		933		556
Due to Abbott Laboratories		876		923
Dividends payable		643		—
Salaries, wages and commissions		621		523
Royalty license arrangements		443		398
Other		1,531		1,718
Accounts payable and accrued liabilities	$	6,448	$	5,734

Schedule of long-term liabilities

as of December 31 (in millions)	2013		2012
Deferred income taxes	$	570	$	360
Pension and other post-employment benefits		1,628		979
Other		1,337		900
Long-term liabilities	$	3,535	$	2,239